Related Experiment Video
Updated: Jan 20, 2026
Derivation of Human Embryonic Stem Cells by Immunosurgery
Published on: December 13, 2007
Inhibition of HMGA2 Leads to Reduced Cell Proliferation and Increased Apoptosis in Human Embryonal Carcinoma Cell
Marco De Martino1, Matteo Lampitto2, Alfredo Fusco1
1Dipartimento Di Medicina Molecolare e Biotecnologie Mediche, Scuola Di Medicina e Chirurgia Di Napoli, Università degli Studi di Napoli 'Federico II', Naples, Italy.
Background:
The most prevalent solid tumors in young men are testicular germ cell tumors (TGCTs), and embryonal carcinoma is the most common subtype among non-seminomatous germ cell tumors (NSGCTs). Despite the excellent cure rates of cisplatin-based chemotherapy, resistance develops in 15%-30% of patients with metastatic cancer, which results in a poor prognosis. The overexpression of the High Mobility Group A2 (HMGA2) protein has been linked to treatment resistance and cancer aggressiveness. It is well known that this protein promotes carcinogenesis.
Objective:
The purpose of this work was to investigate the functional role of HMGA2 in EC cell migration, survival, and proliferation, focusing on its role as a potential therapeutic target in cisplatin-resistant ECs.
Materials And Methods:
We employed human EC cell lines EP2102 and GCT27, as well as the cisplatin-resistant (CisR) versions of these cell lines that were produced by prolonged drug treatment. siRNA transfection was used to suppress HMGA2 expression. Growth curve and colony formation tests were used to measure cell proliferation. Apoptosis was assessed by Annexin V staining followed by flow cytometry, cell cycle distribution was analyzed by flow cytometry, and cell migration was detected by Boyden Chamber Assays.
Results:
In both parental and resistant EC cell lines, HMGA2 knockdown markedly decreased proliferation. After HMGA2 knockdown, flow cytometric analysis revealed S phase arrest. Apoptosis was significantly elevated, especially in cells that were resistant to cisplatin. In addition, all HMGA2-depleted cell lines showed decreased migration. These impacts were true for both the GCT27 and EP2102 models.
Discussion:
The data suggest that HMGA2 is necessary to preserve the EC cells' malignant characteristics. Its silencing interferes with several cancer-related functions, including motility, survival, and cell cycle progression. These results indicate HMGA2's participation in chemoresistance mechanisms and are consistent with its role in other solid cancers.
Conclusion:
Our results indicate a role of HMGA2 in the EC, because its inhibition reduces cell malignant characteristics, and may represent a viable therapeutic target to improve the prognosis of CisR TGCTs.
Insights
High Mobility Group A2 (HMGA2) protein is crucial for embryonal carcinoma (EC) cell survival and proliferation. Silencing HMGA2 in cisplatin-resistant testicular germ cell tumors (TGCTs) offers a potential therapeutic strategy to improve patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Testicular germ cell tumors (TGCTs) are common in young men, with embryonal carcinoma (EC) being a frequent subtype.
- Cisplatin resistance affects 15-30% of metastatic TGCT patients, leading to poor prognoses.
- High Mobility Group A2 (HMGA2) overexpression correlates with treatment resistance and aggressive cancer phenotypes, promoting carcinogenesis.
Purpose of the Study:
- To investigate the functional role of HMGA2 in EC cell migration, survival, and proliferation.
- To evaluate HMGA2 as a potential therapeutic target in cisplatin-resistant ECs.
Main Methods:
- Utilized human EC cell lines (EP2102, GCT27) and their cisplatin-resistant counterparts.
- Suppressed HMGA2 expression using siRNA transfection.
- Assessed cell proliferation (growth curves, colony formation), apoptosis (Annexin V staining, flow cytometry), cell cycle (flow cytometry), and migration (Boyden Chamber Assays).
Main Results:
- HMGA2 knockdown significantly reduced proliferation in both parental and resistant EC cell lines.
- HMGA2 depletion induced S phase arrest and elevated apoptosis, particularly in cisplatin-resistant cells.
- Reduced cell migration was observed in HMGA2-depleted EC cell lines.
Conclusions:
- HMGA2 is essential for maintaining the malignant characteristics of EC cells.
- HMGA2 silencing impairs EC cell motility, survival, and cell cycle progression.
- HMGA2 inhibition may overcome chemoresistance mechanisms and serve as a therapeutic target for cisplatin-resistant TGCTs.
More Related Videos
09:57In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
Published on: March 5, 2019
12:35Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
Published on: September 3, 2016
Related Concept Videos
11:56Derivation of Human Embryonic Stem Cells by Immunosurgery
the body suggests that they hold great promise for both medical applications and as a research
tool for addressing fundamental questions in development and disease. Here, we provide a
concise, step-by-step protocol for the derivation of human embryonic stem cells from embryos
by immunosurgical isolation of the inner cell...
09:57In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines
12:35Comparison of Three Different Methods for Determining Cell Proliferation in Breast Cancer Cell Lines
09:38Passaging HuES Human Embryonic Stem Cell-lines with Trypsin.
09:03Profiling Individual Human Embryonic Stem Cells by Quantitative RT-PCR
13:11Video Bioinformatics Analysis of Human Embryonic Stem Cell Colony Growth